Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 1216 AL 1230

Empirical assessment of biases in cerebrospinal fluid biomarkers of Alzheimer's disease: an umbrella review and re-analysis of data from meta-analyses

Jeong DY, Lee J, Kim JY, Lee KH, Li H, Lee JY, Jeong GH, Yoon S, Park EL, Hong SH, Kang JW, Song TJ, Leyhe T, Eisenhut M, Kronbichler A, Smith L, Solmi M, Stubbs B, Koyanagi A, Jacob L, Stickley A, Thompson T, Dragioti E, Oh H, Brunoni AR, Carvalho AF, Kim MS, Yon DK, Lee SW, Yang JM, Ghayda RA, Shin JI, Fusar-Poli P.

Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1536-1547. doi: 10.26355/eurrev_202102_24862.

Alzheimer Disease Clinical Trials Targeting Amyloid: Lessons Learned From Success in Mice and Failure in Humans

Reiss AB, Montufar N, DeLeon J, Pinkhasov A, Gomolin IH, Glass AD, Arain HA, Stecker MM.

Neurologist. 2021 Mar 4;26(2):52-61. doi: 10.1097/NRL.0000000000000320.

Alzheimer's disease and its treatment by different approaches: A review

Srivastava S, Ahmad R, Khare SK.

Eur J Med Chem. 2021 Apr 15;216:113320. doi: 10.1016/j.ejmech.2021.113320. Epub 2021 Feb 23.

Association between CSF Aβ42 and amyloid negativity in patients with different stage mild cognitive impairment

He B, Wang L, Xu B, Zhang Y; Alzheimer’s Disease Neuroimaging Initiative.

Neurosci Lett. 2021 May 29;754:135765. doi: 10.1016/j.neulet.2021.135765. Epub 2021 Mar 2.

ADAM10 Plasma and CSF Levels Are Increased in Mild Alzheimer's Disease

Pereira Vatanabe I, Peron R, Mantellatto Grigoli M, Pelucchi S, De Cesare G, Magalhães T, Manzine PR, Figueredo Balthazar ML, Di Luca M, Marcello E, Cominetti MR.

Int J Mol Sci. 2021 Feb 28;22(5):2416. doi: 10.3390/ijms22052416.

Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring

van Oostveen WM, de Lange ECM.

Int J Mol Sci. 2021 Feb 20;22(4):2110. doi: 10.3390/ijms22042110.

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework

Leuzy A, Ashton NJ, Mattsson-Carlgren N, Dodich A, Boccardi M, Corre J, Drzezga A, Nordberg A, Ossenkoppele R, Zetterberg H, Blennow K, Frisoni GB, Garibotto V, Hansson O.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2121-2139. doi: 10.1007/s00259-021-05258-7. Epub 2021 Mar 5.

The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers

Ashton NJ, Leuzy A, Karikari TK, Mattsson-Carlgren N, Dodich A, Boccardi M, Corre J, Drzezga A, Nordberg A, Ossenkoppele R, Zetterberg H, Blennow K, Frisoni GB, Garibotto V, Hansson O.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2140-2156. doi: 10.1007/s00259-021-05253-y. Epub 2021 Mar 6.

An Introduction to Ultrasensitive Assays for Plasma Tau Detection

Ding XL, Tuo QZ, Lei P.

J Alzheimers Dis. 2021;80(4):1353-1362. doi: 10.3233/JAD-201499.

Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial

Nasrallah IM, Gaussoin SA, Pomponio R, Dolui S, Erus G, Wright CB, Launer LJ, Detre JA, Wolk DA, Davatzikos C, Williamson JD, Pajewski NM, Bryan RN; SPRINT Research Group.

JAMA Neurol. 2021 May 1;78(5):568-577. doi: 10.1001/jamaneurol.2021.0178.

Molecular imaging and fluid biomarkers of Alzheimer's disease neuropathology: an opportunity for integrated diagnostics

Garibotto V, Boccardi M, Chiti A, Frisoni GB.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2067-2069. doi: 10.1007/s00259-020-05116-y.

Blood tests to screen for Alzheimer's disease

Husain M.

Brain. 2021 Mar 3;144(2):355-356. doi: 10.1093/brain/awaa462.

Comparison of the clinical impact of 2-[18F]FDG-PET and cerebrospinal fluid biomarkers in patients suspected of Alzheimer's disease

Gjerum L, Andersen BB, Bruun M, Simonsen AH, Henriksen OM, Law I, Hasselbalch SG, Frederiksen KS.

PLoS One. 2021 Mar 12;16(3):e0248413. doi: 10.1371/journal.pone.0248413. eCollection 2021.

Therapy for Alzheimer's disease: Missing targets and functional markers?

Stoiljkovic M, Horvath TL, Hajós M.

Ageing Res Rev. 2021 Jul;68:101318. doi: 10.1016/j.arr.2021.101318. Epub 2021 Mar 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias